RU2601307C2 - Инденовые производные для применения в лечении воспалительного заболевания кишечника - Google Patents

Инденовые производные для применения в лечении воспалительного заболевания кишечника Download PDF

Info

Publication number
RU2601307C2
RU2601307C2 RU2013155270/04A RU2013155270A RU2601307C2 RU 2601307 C2 RU2601307 C2 RU 2601307C2 RU 2013155270/04 A RU2013155270/04 A RU 2013155270/04A RU 2013155270 A RU2013155270 A RU 2013155270A RU 2601307 C2 RU2601307 C2 RU 2601307C2
Authority
RU
Russia
Prior art keywords
compound
tert
mice
compounds
dss
Prior art date
Application number
RU2013155270/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2013155270A (ru
Inventor
Хелен ШЕРИДАН
Нил ФРАНКИШ
Original Assignee
Венантиус Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Венантиус Лимитед filed Critical Венантиус Лимитед
Publication of RU2013155270A publication Critical patent/RU2013155270A/ru
Application granted granted Critical
Publication of RU2601307C2 publication Critical patent/RU2601307C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/19—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups having unsaturation outside the aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/17—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
RU2013155270/04A 2011-07-22 2012-07-20 Инденовые производные для применения в лечении воспалительного заболевания кишечника RU2601307C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161510628P 2011-07-22 2011-07-22
US61/510,628 2011-07-22
PCT/IE2012/000037 WO2013014659A1 (en) 2011-07-22 2012-07-20 Indene derivatives for use in the treatment of inflammatory bowel disease

Publications (2)

Publication Number Publication Date
RU2013155270A RU2013155270A (ru) 2015-08-27
RU2601307C2 true RU2601307C2 (ru) 2016-11-10

Family

ID=46584089

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013155270/04A RU2601307C2 (ru) 2011-07-22 2012-07-20 Инденовые производные для применения в лечении воспалительного заболевания кишечника

Country Status (11)

Country Link
US (1) US9586885B2 (enExample)
EP (1) EP2734496A1 (enExample)
JP (1) JP5898768B2 (enExample)
CN (1) CN103764608B (enExample)
AU (1) AU2012288404A1 (enExample)
BR (1) BR112014001551A2 (enExample)
CA (1) CA2839606A1 (enExample)
NZ (1) NZ618936A (enExample)
RU (1) RU2601307C2 (enExample)
TW (1) TWI537246B (enExample)
WO (1) WO2013014659A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013014660A1 (en) * 2011-07-22 2013-01-31 Venantius Limited Indane dimers for use in the treatment of autoimmune inflammatory disease
CN110426464B (zh) * 2019-07-08 2022-03-04 苏州正济药业有限公司 一种葡甲胺中异构体的hplc检测方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6297399B1 (en) * 1995-12-06 2001-10-02 Venantius Limited Indane compounds with smooth muscle relaxing and/or mast cell stabilizing and/or anti-inflammatory activity

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19619036A1 (de) 1996-04-30 1997-11-13 Schering Ag Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
AU3899097A (en) * 1996-08-05 1998-02-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted aromatic compounds
EP1032385A1 (en) * 1997-11-20 2000-09-06 Children's Medical Center Corporation Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cellproliferation, diarrhe and scours
US20020128256A1 (en) * 1997-11-20 2002-09-12 Carlo Brugnara Methods for the treatment or prevention of inflammatory diseases characterized by abnormal cell proliferation
ES2240201T3 (es) * 1999-10-20 2005-10-16 Tanabe Seiyaku Co., Ltd. Inhibidores de la adhesion molecular mediada por la alfa-l beta-2.
DE602004031410D1 (de) 2003-04-15 2011-03-31 Aquinox Pharmaceuticals Inc Inden derivate als pharmazeutika
US7592461B2 (en) * 2005-12-21 2009-09-22 Bristol-Myers Squibb Company Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
WO2013014660A1 (en) 2011-07-22 2013-01-31 Venantius Limited Indane dimers for use in the treatment of autoimmune inflammatory disease
EP2864279B1 (en) 2012-05-24 2016-11-02 Venantius Limited Compounds for use in the treatment of autoimmune inflammatory disease
EP2855416A1 (en) 2012-05-24 2015-04-08 Venantius Limited Indane dimers for use in the treatment of autoimmune inflammatory disease

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6297399B1 (en) * 1995-12-06 2001-10-02 Venantius Limited Indane compounds with smooth muscle relaxing and/or mast cell stabilizing and/or anti-inflammatory activity
US6300376B1 (en) * 1995-12-06 2001-10-09 Venantius Limited Indane dimer compounds and their pharmaceutical use

Also Published As

Publication number Publication date
RU2013155270A (ru) 2015-08-27
US9586885B2 (en) 2017-03-07
WO2013014659A1 (en) 2013-01-31
TW201311637A (zh) 2013-03-16
CN103764608B (zh) 2016-02-03
CN103764608A (zh) 2014-04-30
JP5898768B2 (ja) 2016-04-06
HK1196597A1 (zh) 2014-12-19
EP2734496A1 (en) 2014-05-28
JP2014524921A (ja) 2014-09-25
US20140128466A1 (en) 2014-05-08
NZ618936A (en) 2015-07-31
TWI537246B (zh) 2016-06-11
CA2839606A1 (en) 2013-01-31
AU2012288404A1 (en) 2014-01-09
BR112014001551A2 (en) 2017-06-13

Similar Documents

Publication Publication Date Title
CN105814072B (zh) 一种五环三萜结构修饰化合物及其制备方法和应用
RU2601307C2 (ru) Инденовые производные для применения в лечении воспалительного заболевания кишечника
JPH0449533B2 (enExample)
TWI537245B (zh) 用於治療自體免疫發炎疾病之化合物
EP0588797B1 (en) N- 4,5-dihydroxy- and 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracene-yl]carbonyl]amino acids useful in the therapy of osteoarticular affections
EP3756660B1 (en) Medicament having anti-inflammatory bowel disease function, and preparation method therefor and application thereof
JP3061865B2 (ja) 芳香族カルボン酸エステル、その製造および医薬としてのその用途
US4134989A (en) Guaiacol p-isobutyl hydratropate
CN105541591B (zh) 1‑（4‑羟基‑3‑芳基苯基）‑2‑丙酮及其制备方法与应用
TW418186B (en) Retinoid-like compounds
US9260376B2 (en) Compounds for use in the treatment of immune related inflammatory disease
Xin et al. Identification of a new azoreductase driven prodrug from bardoxolone methyl and 5-aminosalicylate for the treatment of colitis in mice
US20150141506A1 (en) Indane dimers for use in the treatment of autoimmune inflammatory disease
KR20210123321A (ko) 류코트리엔 합성 억제제
HK1196597B (en) Indene derivatives for use in the treatment of inflammatory bowel disease
US11731947B2 (en) Deuterated antimicrobial compounds
AU711933B2 (en) Dimethyl-substituted cyclohexadiene derivatives
EP3753559A1 (en) Colitis improving agent
WO2024098856A1 (zh) 一种抗流感病毒衍生物及其用途
CN114478464A (zh) 一种炎症小体选择性抑制剂及其合成方法和应用
CN111138282A (zh) 绿原酸l-精氨酸盐及其用途
CN110938001A (zh) 绿原酸乙醇胺盐及用途
JPWO1999037633A1 (ja) イソフラバン誘導体およびそれを含有してなる免疫賦活作用を有する組成物

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20170721